Opioid victims are not getting a "fair shake" in potential $7.4 billion settlement, a claimant in the Purdue Pharmacy ...

Here's why people alleging Purdue Pharma's opioids harmed them may not see much of the proposed $7.4 billion settlement in a bankruptcy case.

The Supreme Court of the US has rejected a bankruptcy deal that would settle opioid litigation against Purdue Pharma ... pot put on the table to settle claims that Purdue fuelled the opioid ...

Judge Littlefield is deciding whether to permit several child sexual abuse lawsuits against the Roman Catholic Diocese of Albany to go to trial as a method to kick start settlement discussions.

NEW YORK, Feb 25 (Reuters) - Purdue Pharma told a U.S. bankruptcy ... to $750 million set aside for personal injury claims in Purdue’s previous bankruptcy plan. Lane said Tuesday that he was ...

A judge in the US has approved the sale of Purdue Pharma’s ... part of the bankruptcy proceedings related to the drugmaker’s proposed $10 billion settlement of claims that it helped to fuel ...

Purdue Pharma, 603 U.S. 204 (2024), where a ... third-party nondebtors without the consent of affected claim holders. The bankruptcy bar and courts are now attempting to determine the breadth ...

Mallinckrodt Pharmaceuticals and Endo have agreed to combine in a nearly $7bn deal after the pair emerged from bankruptcy processes linked to liabilities over the US opioid crisis.

Purdue Pharma planned to exit bankruptcy last year under terms that gave the Sacklers a full release from all civil opioid claims even though they themselves were not declaring bankruptcy.

Supreme Court hears case that could shield Purdue Pharma owners from opioid lawsuits The Supreme Court heard arguments in one of the most important corporate bankruptcy cases in decades.

A New York bankruptcy judge’s recognition of a Mexican lender’s foreign restructuring with nonconsensual liability releases ...